Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The benefits and costs of changing treatment technique in electroconvulsive therapy due to insufficient improvement of a major depressive episode

Brain stimulation(2020)10.1016/j.brs.2020.06.016Source: DataRank Database

The benefits and costs of changing treatment technique in electroconvulsive therapy due to insufficient improvement of a major depressive episode is a research paper published in Brain stimulation (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (26 grants)OA: goldTopics (34)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Joan Prudic,D. P. Devanand,Mitchell S. Nobler,Roger F. Haskett,Benoit H. Mulsant ORCID

Live enrichment

PubMed:32585354 PMC:PMC7494636

National Institute of Mental Health

Grant: RO1 MH61594

National Institute of Mental Health

Grant: R01 MH35636:01\u201327

Wake Forest University

Grant: R01 MH61591

NIMH NIH HHS

Grant: R01 MH061591

NIMH NIH HHS

Grant: R01 MH061609

NIMH NIH HHS

Grant: R01 MH061621

Wake Forest University

Grant: RO1 MH61621

NIMH NIH HHS

Grant: R01 MH061594

National Institute of Mental Health

Grant: R01 MH61609

NIMH NIH HHS

Grant: R01 MH035636

National Institute of Mental Health

Grant: R01 MH35636

Canadian Institutes of Health Research

Grant: unidentified

unidentified

Merck

Sunovion

National Institutes of Health

Patient-Centered Outcomes Research Institute

Wyeth

Fondation Brain Canada

Bristol-Myers Squibb

Centre for Addiction and Mental Health Foundation

Janssen Pharmaceuticals

Eli Lilly and Company

Wyeth Pharmaceuticals

CIHR

Canadian Institutes of Health Research

Pfizer

goldLicense: CC BY

https://doi.org/10.1016/j.brs.2020.06.016

http://www.brainstimjrnl.com/article/S1935861X20301340/pdf

https://pubmed.ncbi.nlm.nih.gov/32585354

https://doaj.org/article/15bda3b0d2cb480c940730467e3d4d70

https://dx.doi.org/10.1016/j.brs.2020.06.016

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansRecurrenceAntidepressive AgentsTreatment OutcomeFollow-Up StudiesElectroconvulsive TherapyAdultAgedMiddle AgedCost-Benefit AnalysisFemaleMaleMajor Depressive Disorder

Keywords

RelapseRetrograde AmnesiaElectroconvulsive Therapy (Ect)Switching StrategyAdultMaleMajor Depressive DisorderCost-Benefit AnalysisNeurosciences. Biological psychiatry. NeuropsychiatryMiddle AgedAntidepressive AgentsTreatment OutcomeRecurrenceHumansFemaleElectroconvulsive TherapyRC321-571AgedFollow-Up Studies

Sustainable Development Goals

SDG 3: 3. Good health

The benefits and costs of changing treatment technique in electroconvulsive therapy due to insufficient improvement of a major depressive episode

FAIR Checklist

Authors (8)

Funding (26 grants)

Open Access

Topics

Annotations (Europe PMC)